Cardiovascular disease and COVID-19: a consensus paper from the ESC working group on coronary pathophysiology & microcirculation, ESC working group on …
E Cenko, L Badimon, R Bugiardini… - Cardiovascular …, 2021 - academic.oup.com
The cardiovascular system is significantly affected in coronavirus disease-19 (COVID-19).
Microvascular injury, endothelial dysfunction, and thrombosis resulting from viral infection or …
Microvascular injury, endothelial dysfunction, and thrombosis resulting from viral infection or …
Association of COVID-19 with major arterial and venous thrombotic diseases: a population-wide cohort study of 48 million adults in England and Wales
Background: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
induces a prothrombotic state, but long-term effects of COVID-19 on incidence of vascular …
induces a prothrombotic state, but long-term effects of COVID-19 on incidence of vascular …
Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme
EL Petersen, A Goßling, G Adam… - European Heart …, 2022 - academic.oup.com
Aims Long-term sequelae may occur after SARS-CoV-2 infection. We comprehensively
assessed organ-specific functions in individuals after mild to moderate SARS-CoV-2 …
assessed organ-specific functions in individuals after mild to moderate SARS-CoV-2 …
Current and emerging knowledge in COVID-19
COVID-19 has emerged as a pandemic leading to a global public health crisis of
unprecedented morbidity. A comprehensive insight into the imaging of COVID-19 has …
unprecedented morbidity. A comprehensive insight into the imaging of COVID-19 has …
Clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19
Importance The risk of venous thromboembolism (VTE) in ambulatory COVID-19 is
controversial. In addition, the association of vaccination with COVID-19–related VTE and …
controversial. In addition, the association of vaccination with COVID-19–related VTE and …
Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study
E Burn, T Duarte-Salles… - The Lancet Infectious …, 2022 - thelancet.com
Background There are few data on the incidence of thrombosis among COVID-19 cases,
with most research concentrated on hospitalised patients. We aimed to estimate the …
with most research concentrated on hospitalised patients. We aimed to estimate the …
Increased blood viscosity and red blood cell aggregation in patients with COVID‐19
E Nader, C Nougier, C Boisson… - American journal of …, 2022 - Wiley Online Library
The aim of this study was to (1) analyze blood viscosity, red blood cell (RBC) deformability,
and aggregation in hospitalized patients with Coronavirus disease 19 (COVID‐19);(2) test …
and aggregation in hospitalized patients with Coronavirus disease 19 (COVID‐19);(2) test …
[HTML][HTML] Review of COVID-19 viral vector-based vaccines and COVID-19 variants
The concept of viral vector-based vaccine was introduced in 1972 by Jackson et al and in
1982 Moss et al introduced the use of vaccinia virus as a transient gene expression vector …
1982 Moss et al introduced the use of vaccinia virus as a transient gene expression vector …
Clinical features of thrombosis and bleeding in COVID-19
MR Thomas, M Scully - Blood, The Journal of the American …, 2022 - ashpublications.org
Infection with the SARS-CoV-2 virus, resulting in COVID-19 disease, has presented a
unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is …
unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is …